The FDA critical path initiative and its influence on new drug development

Annual Review of Medicine
Janet Woodcock, Raymond Woosley

Abstract

Societal expectations about drug safety and efficacy are rising while productivity in the pharmaceutical industry is falling. In 2004, the US Food and Drug Administration introduced the Critical Path Initiative with the intent of modernizing drug development by incorporating recent scientific advances, such as genomics and advanced imaging technologies, into the process. An important part of the initiative is the use of public-private partnerships and consortia to accomplish the needed research. This article explicates the reasoning behind the Critical Path Initiative and discusses examples of successful consortia.

References

Feb 28, 2003·Journal of Health Economics·Joseph A DiMasiHenry G Grabowski
Mar 9, 2006·Health Affairs·Christopher P Adams, Van V Brantner
Aug 11, 2006·The New England Journal of Medicine·Alastair J J Wood
Oct 25, 2006·Annual Review of Medicine·C Thomas Caskey
Jan 30, 2007·Clinical Pharmacology and Therapeutics·J Woodcock
Jan 30, 2007·Clinical Pharmacology and Therapeutics·L J Lesko
Jan 1, 2006·Toxicology Mechanisms and Methods·Shiew-Mei HuangLawrence J Lesko

❮ Previous
Next ❯

Citations

Dec 4, 2013·Psychopharmacology·Kenneth A Perkins, Caryn Lerman
Feb 7, 2013·European Journal of Clinical Pharmacology·Alienor Berges, Chao Chen
Apr 29, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Anders Nordström, Rolf Lewensohn
Mar 31, 2011·International Journal of Computer Assisted Radiology and Surgery·Alexander HorschMatthias Elter
Sep 1, 2008·Journal of Cardiovascular Translational Research·Raymond L Woosley
Mar 2, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Julie A LynchChristopher S Lathan
Jan 5, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zvia Agur, Stanimir Vuk-Pavlović
Jan 10, 2012·Nature Medicine·Richard S BlumbergFrank O Nestle
Mar 8, 2012·Nature Medicine·Michel Goldman
Feb 20, 2013·Nature Reviews. Rheumatology·William H RobinsonJeremy Sokolove
Jun 21, 2011·Omics : a Journal of Integrative Biology·Fabio BagnoliRino Rappuoli
Dec 13, 2012·Journal of the National Cancer Institute·Yaacov Richard LawrenceAdam P Dicker
May 8, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jacqueline M Tarrant
Oct 15, 2009·The Cancer Journal·Daniel S W TanPaul Workman
Nov 21, 2008·American Journal of Physiology. Renal Physiology·Eisei NoiriTakeshi Sugaya
Jun 19, 2010·American Journal of Respiratory and Critical Care Medicine·Eric B MilbrandtDerek C Angus
Feb 2, 2013·Clinical and Translational Medicine·Michel GoldmanBarbara B Mittleman
Dec 27, 2011·Critical Reviews in Biomedical Engineering·Robert K Amanfu, Jeffrey J Saucerman
Feb 20, 2010·American Journal of Public Health·Alastair Matheson
Oct 1, 2008·Biomarkers in Medicine·Sabine ClassenJoachim L Schultze
Oct 12, 2010·Indian Journal of Pharmacology·Rajiv Mahajan, Kapil Gupta
Nov 22, 2011·Future Medicinal Chemistry·Graeme M Robertson, Lorenz M Mayr
Oct 11, 2012·Revista brasileira de hematologia e hemoterapia·Carmino Antonio de Souza
Jun 12, 2013·Pharmacogenomics·James J ChenHung-Chia Chen
Jul 3, 2013·Biochemical Pharmacology·David R Webb
Jun 15, 2014·Drug Discovery Today·Majid Moridani, Sam Harirforoosh
Nov 2, 2014·Nature Reviews. Drug Discovery·Martha Brumfield
Dec 3, 2014·Academic Radiology·Jason N ItriAkash P Kansagra
Oct 1, 2008·Expert Opinion on Drug Discovery·Yuan Wen, Shang-Tian Yang
Jul 27, 2014·Expert Opinion on Drug Discovery·Ping Zhang, Vladimir Brusic
May 30, 2013·COPD·Richard CasaburiJohn Walsh
Feb 16, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Hans Leuenberger, Michael N Leuenberger
Jan 1, 2009·Journal of Pharmaceutical Sciences·Rodney J Y Ho, Jenny Y Chien
May 29, 2013·Journal of Pharmaceutical Sciences·Shiew-Mei HuangIssam Zineh
Jan 17, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Priya SatalkarDavid Shaw

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
imaging techniques

Software Mentioned

MATT
Path

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.